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Summary
We have previously expressed in transgenic mice a chimeric H-2Kd/Kk protein called C31, which
contains the extracellular a1 domain of Kd, whereas the rest of the molecule is of Kk origin.
This molecule functions as a restriction element for alloreactive and influenza A-specific cytotoxic
T lymphocytes (CTL) but is only weakly expressed at the cell surface of splenocytes. Here, we
show that the low cell surface expression is the result ofslow intracellular transport and processing
of the C31 protein. A set of hybrid molecules between Kd and Kk were used to localize the
regions in major histocompatibility complex (MHC) molecules that are important for their
intracellular transport and to further localize the structuresresponsible for binding to the adenovirus
2 E3/19K protein. This protein appears to be an important mediator of adenovirus persistence.
It acts by binding to the immaturely glycosylated forms ofMHC classI proteins in the endoplasmic
reticulum (ER), preventing theirpassage to the cell surface and thereby reducing the recognition
ofinfected cells by virus-specific T cells. We find the surprising result that intracellular transport
and E3/19K binding are controlled primarily by the first half of the second domain of Kd, thus
localizing these phenomena to the five polymorphic residues in this region of the Kd protein.
This result implies that the E3/19K protein may act by inhibiting peptide binding or by disrupting
the oligomerization ofMHC class I molecules required for transport out ofthe ER. Alternatively,
the E3/19K protein may inhibit the function of a positively acting transport molecule necessary
for cell surface expression of MHC class I molecules.
T
he class I antigens of the MHC consist of a family of
highly polymorphic cell surface glycoproteins whose pri-
mary function is to bind and present foreign peptides to CTL
(1-3). MHC class I antigens are composed of an H chain
(45,000 mol wt) that contains three extracellular domains
(al, a2, and 0) and a noncovalently associated L chain
(12,000 mol wt) called 02-microglobulin (4). The crystal
structure of the human class I proteins HLAA2 (5, 6) and
HLA-Aw68 (7) reveals that the cil and a2 domains form a
superdomain that is involved in peptide binding. This struc-
ture is stabilized by the 0 and 02-microglobulin domains,
which lie proximal to the plasma membrane (5, 6).
The intracellular transport of MHC class I molecules is
only partially understood and appears to be regulated at sev-
eral different levels. In all but exceptional cases, the transport
of the MHC class I H chain out of the rough endoplasmic
reticulum (MR)' requires association with 02-microglob-
ulin (8-12). Previously, this association was thought to con-
trol the rate of MHC class I passage through the cell (11,
13). However, current evidence suggests that this step may
be dependent on positively acting assembly protein(s), which
are constitutively expressed in B and T cell hybridomas (14),
but can be induced by IFN--y in some fibrosarcomas (15).
Furthermore, recent data suggest that this step may also be
controlled by the binding of peptides to the H chain, which
then allows the association with )32-microglobulin (16). At
another level, MHC molecules that are highly homologous
have very different transport rates, and it seems likely that
'Abbreviations used in this paper: Endo D, endoglycosidase D; Endo H,
endoglycosidase H; ER, endoplasmic reticulum; RER, rough endoplasmic
reticulum.
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globulin and H chain or a2-microglobulin, H chain, and
peptides controls its rate ofprocessing through the cell (16-18).
This process could act through positively acting transport
proteins or, alternatively, it could act at the level of oligo-
merization ofMHC molecules. It follows that polymorphic
structural elements in MHC proteins that do not allow or-
dered oligomerization can control the rate ofMHC transport.
The functional implications of differential control mecha-
nisms for MHC class I transport may be best demonstrated
in responses against tumors. The lack of cell surface MHC
class I proteins in some virally induced tumors may lead to
the immunological nonresponsiveness ofT cells (19). During
adenovirus infections, a prime inhibitor ofMHC expression
is the E3/19K protein. In virally infected cells, this protein
binds specifically in the RER to the a1 and a2 domains of
MHC class I proteins and prevents cell surface expression of
MHC class I proteins (20, 21). Thus, this protein can subvert
immunological recognition by acting to inhibit intracellular
transport of MHC molecules (22-25).
Here, we report that a recombinant MHC class I protein
containing the al and the ot2 domains from two different
alleles is severely inhibited in its transport. The rate of trans-
port is normal ifthe first half ofthe a2 domain derived from
the same allele as the al domain is added. Therefore, this
part of the a2 domain can contribute to the transport and
cell surface expression of MHC antigens. We also find that
similar structures are important for binding to the adenovirus
protein E3/19K. These results are discussed as they relate to
peptide binding, oligomerization, and trans-acting molecules
important for MHC class I expression.
Materials .and Methods
Cell Culture, Cell Labeling, Immunoprecipitation, andSDS-PAGE.
Cell lines were derived and propagated as previouslydescribed (21,
26-30). Cells were maintained in DMEM containing 10% FCS.
Pulse-chase experiments were carried out essentially as described
previously(29) with the following modifications. Cellsto be meta-
bolically labeled were washed twice in methionine-free medium
before being incubated at 37°C with [3'S]methionine (1,200 Ci/
mmol; Amersham International, Amersham, UK) at a concentra-
tion of 200 uCi/ml for 15 min. The cells were washed twice in
warm complete medium before being resuspended in complete
medium until the end of the chase time. At this point, cells were
pelleted and resuspended in lysis buffer (20 mM Hepes, pH 7.5,
100 mM NaCI, 5 mM MgCI,, 1% NPA0, and 40 wg/ml PMSF).
To clear the lysates from the cellular debris, the tubes were spun
at 14,000 g for 30 min. The supernatants were incubated with 3 P.1
of normal rabbit serum on ice for 15 min. Protein A-Sepharose
(100 IAl of a 1:1 buffer/Sepharose slurry) was then added, and the
mixtures were incubated for an additional 60 min before being spun
at 14,000 g for 5 min. Immunoprecipitations from the precleared
lysates werecarried out by incubating with 2 pl ofthemonoclonal
ascites fluid for 45 min, followed by 45 14 of protein A-Sepharose
for 45 min. The beadswere washed and the proteins were analyzed
by 10-15% SDS-PAGE as described previously (29).
Endogl)vosidase Treatments ofImmumprecipitations.
￿
For endogly-
cosidase digestion, immunoprecipitates were carried out in dupli-
cate as above. After washing in 10 mM Tris buffer, pH 7.5, im-
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munoprecipitates were resuspended either in 25 p1 of70 mM citrate
buffer, pH 5.5, alone or in 25 pl of buffer containing 2.5 mU of
endoglycosidase H (EndoH) (Boehringer Mannheim Biochemicals,
Indianapolis, IN). These samples were incubated for 18 h at 37°C
before addingSDS sample buffer. Endoglycosidase D (EndoD) treat-
ment was as above, except that 200 mM phosphate buffer, pH 6.5,
was used.
Tansfection.
￿
Transfection of the J4 and the J3 constructs into
the E3/19K-expressing cellline 293.12 was carried out as described
previously (28). The hygromycin B resistance gene was used to
cotransfect the cells, and the cells were selected in 180 Rg/ml of
hygromycin (Calbiochem-Behring Corp., American Hoechst Corp.,
San Diego, CA) (28).
Antibodies andAnimals.
￿
All antibodieswere of the IgG2a sub-
class, except the 1A2 antibody (anti-a-tubulin) which is IgG2b
(31). The following additionalantibodieswere used in this study:
34-1-2s (anti-H-21,9) (32); 20-8-4s (anti-Kd first domain specific)
(32); 11-4-1s (anti-Kk) (33); H100-27-55 (anti-H-2k first domain
specific) (34); B9.12.1 (anti-HLA) (35); W6/32 (anti-HLAA, B,
C) (36); 34-5-8s (anti-Dd) (32); 30-5-7s (anti-Ld) (32); 16-3-22
(anti-H-W second domain specific) (32); K9-18 (anti-H-2W
third domain specific) (26); F35-140 (anti-H-2W second domain
specific) (26). Goat anti-mouse IgG2a FITC was obtained from
Southern Biotechnology Associates (Birmingham, AL).
The derivation of the C3H/He x C31 transgenic animals was
described previously (29). DBA/2 (H-2d), BALB/c (H-2d), and
C3H/He (H-2k) were conventionally maintained.
FACS Analysis.
￿
To verify cell surface expressionof the C31 an-
tigenand H-2 antigens in transgenic, DBA/2, and C3H/He mice,
FACS analysis was carried out. Mice were splenectornized, the
spleens were teased into a single cell suspension, the RBC were
removed by flashlysis with distilled water and were washed twice
in PBS containing 0.5% (wt/vol) BSA, 20 mM NaN3, and 20 mM
Hepes, and the viability and cell number were determined by trypan
blueexclusion in a hemocytometer. The splenocytes wereincubated
with mAbs as previously described (29), except that FITC-con-
jugated goat anti-mouse IgG2awas used as the second-step reagent.
After labeling, the cells were fixedin 1.5% (vol/vol)p-formaldehyde.
The fluorescent profiles were obtained by analyzing 10,000 cells
in a semi-logarithmic plot on a FACS IV consort 40 program. FACS
analysis was standardized using fluorescent beads from Flow Cytom-
etry Standard Corp. (Research Triangle Park, NC).
Iodination ofSpknogtes.
￿
Cell surface iodinations ofmouse spleno-
cytes were performed as described previously (37).
Other Reagents. Lactoperoxidase, restriction enzymes, and
DNA-modifying enzymes were from Boehringer Mannheim Bio-
chemicals. Protein A-Sepharose was from Pharmacia Fine Chem-
icals (Uppsala, Sweden). Glucose oxidase was from Sigma Chem-
ical Co. (St. Louis, MO).
Results
We wanted to address whether the structures required for
E3/19K binding to MHC molecules are the same as those
controlling the intracellular transport of MHC molecules.
To compare these two processes, we first examined the trans-
port of MHC molecules and then we used this information
to examine the binding ofMHC class I proteins to E3/19K.
We have previously derived a C3I4 (H-2k) transgenic
mouse that expresses a transgenic Kd/Kk construct, called
pC31, that encodes the signal sequence and cil domain of
Kd and the ct2 and 0 domains, and transmembrane and cy-J
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Figure 1.
￿
FRCS analysis ofMHC class I expression on splenocytes. The
cell surface expression of MHC class I proteins on splenocytes was ana-
lyzed by flow cytometry using mAbs specific for individual MHC pro-
teins or allotypes. Their specificities are indicated in brackets. (A) C3H/He
(H-2k) splenooytes were analyzed with H100-27-55 (H-2k), 15-5-5 (H-2DE),
and 16-3-22 (H-2Kk). (B) C31 x C3H/He (H-2k) splenocytes were ana-
lyzed with the same antibodies as the C3H/He cells, and in addition, the
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toplasmic domains, of Kk. It is expressed at high levels as
a messenger RNA and as a protein in most tissues. It can
also function as a novel restriction element to direct specific
lysis by allogenic (38) and virus-specific CTLs (29). How-
ever, the analysis of C31 cell surface expression revealed that
it is expressed at lower levels than most other MHC class
I proteins. Fig. 1 shows the relative amounts of MHC class
I antigens expressed at the surface of splenocytes from C3H
(H-2k), DBA/2(H-2d), and C3H/C31 transgenic mice using
the FRCS analysis. Note that C31 is expressed at the same
level as the Ld molecule.
To investigate the low levelof C31 surface expression, the
rate of intracellular transport of C31 and its parental mole-
cules, Kk and Kd, was examined. Splenocytes from C3H/
C31 (265-4-1) transgenics and DBA/2 mice were pulsed for
20 min with [35Sjmethionine and then chased for various
times before lysing the cells in buffer containing 1% NP-40
and protease inhibitors. As a first approximation, long chase
periods (6, 12, and 24 h) were used to determine if there
was a defect in C31 processing. The Kk and C31 proteins
were each immunoprecipitated from the transgenic spleno-
cyte lysate while the Kd molecule was immunoprecipitated
from the DBA/2 splenocyte lysates. In examining Fig. 2, it
is apparent that C31 is not processed as quickly as the Kk
and Kd molecules. The Kk molecule is completely processed
from the lowermolecular weight form which likely represents
the RER or cis-Golgi form of the molecule to the mature
form of the molecule by 6 h. Furthermore, the majority of
the Kd molecules are processed to the trans-Golgi/cell sur-
face form of the molecule in 6 h. However, the majority of
the C31 molecule is not processed to the higher molecular
weight cell surface form of the molecule during the 24-h chase
of the experiment. Thus, C31 is much more slowly processed
than either Kk or Kd. To examine this in more detail, this
experiment was repeated on the transgenic splenocytes with
more chase points and with treatment of duplicate samples
with Endo H. The acquisition of Endo H insensitivity is a
marker for the transition of a glycoprotein from the RER
to the medial-Golgi cisternae (39). Fig. 3 shows that most
of the Kk protein is processed to its mature form in 180 min.
The Kd molecule becomes insensitive to Endo H digestion
at the same time as its processed form appears, indicative of
its passage from the RER to the medial-Golgi. The Kd pro-
tein is processed to its mature form in 360 min (data not
shown). On the other hand, the majority of the C31 mole-
cules do not become Endo H insensitive during the time of
the chase period (Fig. 3) . The C31 molecules, which do ap-
pear to become Endo H insensitive (*, probably represent
the small percentage of the total C31 molecules made that
are transported to the cell surface. However, it should be
pointed out that there is -12-fold more C31 than Kk made
in transgenic splenocytes (29) and that the surface expression
antibody 34-1-2 (H-2d and C31) was used to detect the C31 protein. (C)
DBA/2 splenocytes were analyzed with 34-1-2 (H-2d), 20-8-4 (H-2I(d),
34-5-8 (H-2Dd), and 30-5-7 (H-2Ld). The negative control used in all cases
was B9.12.1 (HLA specific). The mean fluorescence is shown above each
profile in brackets.
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￿
Pulse-chase analysis ofMHC
class I proteins in splenocytes. DBA/2
(H-2d) or 253-4-1 (C31 x C3H/He)
transgenic splenocytes were washed and
pulsed with [35S]methionine before being
washed and chased with medium for the
specified times in hours. The cells were har-
vested by lysis in 1% (wt/vol)NP40 . The
antibody 11-4-1 was used to immunopre-
cipitate H-2Kk from the transgenic spleno-
cyte lysates while the antibody 20-8-4 was
used to immunoprecipitate C31 from the
transgenic lysates and H-2Kd from the
DBA/2 lysates . The molecular weight
markers are shown on the right and their
molecular weights (M, x 10-3) on the
left.
Figure 3 .
￿
Pulse-chase and Endo H or EndoD digestion of Kt and C31 in tr-a
￿
geuic splenocytes. Transgenic splenocytes of the 253-4-1 strain (C31
x H-2Kk) were pulsed with [35S]methionine and then washed and chased with medium before being lysed in 1% (wt/vol) NP-40 lysis buffer at the
specified times. The antibody 11-4-1 was used to immunoprecipitate the H-2Kk molecule . The antibody 20-8-4 was used to immunoprecipitate the
C31 molecule. At each point the lysates were immunoprecipitated with the appropriate antibody and used as a control, or treated with Endo H or
Endo D overnight. The molecular weights of the processed forms of the proteins are shown on the left and the maturl form of the Kk and the C31
molecule are indicated (M) to the right . Forms resulting from enzymatic digestion are indicated (S) to the right. The migration and apparent molecular
weight of OVA is shown on the left (46). Times are in minutes (1i', 22, 45, and 90) or in hours (3, 6, and 12) .
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reference 29) . Thus, the majority of the C31 molecules that
aremade seem not to leave the RER/cis-Golgi 24 h after syn-
thesis, and this explains the discrepancy between the amount
ofC31 expressed at the cell surface and the total amount of
C31 molecules made . To try to determine if the majority of
the C31 molecule is always retained in the RER, or if some
of the C31 is eventually transported to the cis-Golgi, a similar
experiment was carried out with the transgenic splenocytes,
except that EndoD was used. Acquisition ofEndoD sensi-
tivity is a marker for the transport of a glycoprotein from
the RER to the cis-Golgi (40), and subsequent re-acquisition
ofEndo D insensitivity is an indication that the glycoprotein
has been transported out of the cis-Golgi . The Endo D-sen-
sitive Man5GlcNAc2 structure is found in the cis-Golgi, is
only a transient intermediate ofWinked carbohydrate pro-
cessing during protein transport, and is therefore not nor-
mally detectable. Fig. 3 shows that C31 becomes partially
sensitive toEndoD digestion after 12 h ofchasing, indicating
that until this time the majority of the molecules are in the
RER. No Endo D-sensitive Kk molecules can be detected
and this implies that the Kk protein is transported very
quickly through the cis-Golgi . The lower molecular weight
form (S) is not due to degradation as it does not appear in
the samples treated with buffer alone.
To demonstrate that the cell surface form oftheC31 mol-
ecule has acquired complexWinked carbohydrate structures
and is normal in respects to otherMHC class I proteins, trans-
genic and BALB/c (H-2d) splenocytes were labeled at the cell
surface with t25I by the lactoperoxidase method and then
different H-2 molecules were specifically immunoprecipitated
in duplicate. One set was treated with Endo H overnight
while the other set was treated with Endo H incubation buffer
alone. Fig. 4 (lanes 3, 5, and 7) shows that Kt, Kd, and C31
can be detected at the cell surface and that these proteins are
not sensitive to Endo H (lanes 4, 6, and 8) . An antibody
(1A2) against tubulin was used as a negative control to ex-
clude the possibility that the iodine penetrated and labeled
internal proteins (lanes 2 and 9) and OVA, which is Endo H
sensitive, was used as a control for the efficiency of the enzy-
matic digestion (data not shown). Therefore, the C31 ex-
pressed at the cell surface is properly processed, and the
20,000-30,000 molecules expressed at the surface of spleno-
cytes account for the functional C31 molecules (29, 38) .
It became of interest at this point to determine the struc-
tural segments that were absent in the C31 molecules but
present in the Kd and Kk molecules, which allowed them to
be processed and transported rapidly through the cell . To ex-
amine this phenomenon, we used intra- and interdomain hy-
brid genes between Kd and Kk (Fig . 5) . Cell lines derived
from the mouse fibroblast cell line 1T22-6 previously trans-
fected with different hybrid genes were analyzed for cell sur-
face expression of the specific genes using monoclonal reagents
that recognize the presence ofindividual protein domains from
Kd or Kk . The cells were examined by flow cytometry. The
20.8.4s-(A), F35.140 (B), andK9.18 (C) antibodies were used
to confirm the presence of the first, second, and third do-
mains of Kd respectively, while the H100.27.55 (D), and
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Figure 4.
￿
Lactopercaadase-catalyzed radio iodination ofBALB/c (H-2d)
and 253-4-1 (C31 x C3H/He) transgenic splenocytes. Splenocytes were
labeled by the lactoperwadase-glucose oxidase method . The cells were lysed
in 1% (wt/vol) NP-40 andimmunoprecipitates were carried out with equal
TCA-precipitable counts. Lanes 1-4 were immunoprecipitated from BALB/c
splenocytes and lanes 5-10 were immunoprecipitated from transgenic spleno-
cytes. As a negative control, the material in lanes 1 and 10 were immuno-
precipitated with anti-HLA (B9.12 .1) . As a control for the labeling of in-
ternal proteins, the material in lanes 2and 9 was immunoprecipitated with
with antitubulin (lA2); the material in lanes 3 and 4 was immunoprecipi-
tated with anti-Kd (20-8-4) ; the material in lanes 5 and 6 was immuno-
precipitated with anti-H-2d/C31 (34-1-2) ; the material in lanes 7 and 8
was immunoprecipitated with anti-H-W (11-4-1). To determine if the
cell surface forms ofthe H-2 class I molecules are susceptible to Endo-H
digestion, duplicate immunoprecipitations were carried out which were
incubated with Endo-H overnight (lanes 4, 6, and 8) . OVA was used as
a positive control for Endo-H digestion (not shown) . The 40,000-mol
wt protein seen in lanes 3 and 4 is most likely the Qa protein (29) .
16.3.22 (E) antibodies were used to respectively identify mol-
ecules containing the first or second domains of Kk . Anti-
body 34.1.2 (G) was used in this experiment to define the
endogenous H-29 molecules expressed in the untransfected
1T22-6 cells . With these reagents we were able to demon-
strate the expression ofindividual domains ofthe hybrid mol-
ecules in each of the transfected 1T22-6 cell lines. More than
this, we find that there is a striking correlation between the
domain structures and the cell surface expression of the par-
ticular molecule. Consistent with the results on the trans-
genic splenocytes, the C31 molecule is expressed at much lower
levels than either the Kd or Kk at the surface of the 1T22-6
cell. This result was consistently reproduced with five indi-
vidually derived C31 1T22-6 transfectants (data not shown) .
However, the molecules that contain, in addition to the first
domain of Kd , the second (C33) or the second and third
(C32) domains of Kd are expressed at levels similar to the
Kd molecule. The intradomain hybrid molecule J4, which
contains the first domain of Kd and the first half of the
second domain of Kd, is expressed at the same level as theW m
Z
J
J
W
v
Kd protein. The results with this construct localize the seg-
ment responsible for complementation of C31 cell surface
expression to the first half of the second domain of Kd. To
show that the third domain does not contribute to this
phenomenon, the C26 protein was also analyzed. This mol-
ecule has the first and third domains of Kd and the second
domain of Kk, and like the C31 molecule, is also expressed
at low levels at the cell surface. Thus, the low level expres-
sion can be linked entirely to elements in the first domain
and the first half of the second domain of Kd.
To try to generalize this finding, the reciprocal constructs
containing the Kk domains in place of the Kd domains were
LOG OF FLUORESCENCE INTENSITY
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Figure 5.
￿
Comparison of the cell surface expression of the H-2Kd/Kk hybrid genes expressed in 1T22-6 cell lines by flow cytometry. The cells were
incubated with (A) 20-8-4 (anti-Kd, domain one), (B) F35-140 (anti-Kd, domain two), (C) K9-18 (anti-Kd, domain three), (D) H100-27-55 (anti-Kk,
domain one), (E) 16-3-22 (anti-Kk, domain two), (F) no first antibody, and (G) 34-1-2 (anti-H-29 endogenously expressed by 1T22-6 cells). The binding
of the first layer of antibody was determined with FITC-conjugated goat anti-mouse Ig and quantified with fluorescent microbeads. The construct
expressed in each of the transfectants is depicted at the top of each of the panels.
analyzed. The C23 and C24, which contain, respectively, the
first three domains of Kk or the first two domains of Kk,
are expressed at about the same level as Kk, while the C25
molecule, which contains the first domain of Kk and the
second and third domains of Kd, is expressed at slightly
lower levels than the Kk protein but not as low as the C31
molecule. Again in the case of this molecule, the addition
of the first half of the second domain of Kk appears to in-
crease the expression of the C25 molecule. The J2 molecule
and the J5 molecule, which contain the corresponding Kd
or Kb segments in the second half of the second domain of
Kk, demonstrate that this region does not contribute to the
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￿
Localization of the segment of Kd that complements C31 transport and processing. Transfected 1T22-6 cells expressing the H-2Kd/Kt
hybrid molecules were pulsed with 1 35Slmethionine and then washed and incubated in medium. The cells were lysed in 1% (wt/vol) NP-40 at the
specified times. The antibody 20-8-4 was used to immunoprecipitate molecules containing the first domain of Kd, and H100-27-55 was used to immu-
noprecipitate molecules containing the first domain of Kti .
cell surface expression ofthe Kk molecule. Thus, the first do-
main together with the first part of the second domain of
H-2Kd, and to a lesser extent H-2Kk, contain amino acids
that strongly influence their cell surface expression .
To determine whether the cell surface expression of the
C31 and the C25 proteins are related to their transport, the
rate of intracellular processing ofhybrid proteins was exam-
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ined in pulse-chase experiments. Fig. 6 shows that in 1T22-
6 cells the mature form of the Kd molecule appears at 45
min and it is completely processed after 3 h (ti/2 = 50 min),
while the mature form of the Kk molecule appears after 22
min and is completely processed at 3 h (ti/2 = 35 min) .
These results parallel those in the splenocytes pulse-chase ex-
periments where the Kk molecule is processed slightly fasterFigure 7.
￿
Characterization of the structure within Kd responsible for the binding to the immunosubversive E3/19K protein of adenovirus 2. 293
cells previously transfected with the gene encoding the E3/19K protein were supertransfected with the hybrid Kd/Kk genes . Cells expressing the hy-
brid genes were selected and then were labeled with [35S]methionine for 20 min, washed, and then chased with medium for 1.5 h before being lysed
in 1% (wt/vol) NP-40. Proteins containing the first domain of Kd were immunoprecipitated with the 34-1-2 antibody, while proteins containing the
first domain ofKk .were immunoprecipitated with H100-27-55 . W6/32 was used to immunoprecipitateHLA class I proteins from 293 cells expressing
the E3/19K protein . The constructs analyzed are depicted at the top of each lane. The ability to bind E3/19K is shown at the bottom of the figure.
than the Kd molecule. The mature form of the C31 protein
can be visualized after 22 min of chasing; however, the pro-
cessing of the C31 molecule is not completed at 720 min
(tv2 = 10 h), and thus the processing of the C31 molecule
may take longer than the division time of the 1T22-6 cells.
It is intriguing that the overall rate of processing of these
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MHC class I proteins is faster in the 1T22-6 cell line than
in splenocytes .
If one compares the processing of the J4 construct with
that of the C31 protein, it is evident that the J4 construct
(tti2 = 55 min) is processed much more rapidly than the
C31 molecule . Similarly, the C33 (tti2 = 50 min) and C32(tv2 = 40 min) molecules are processed at approximately the
same rate as the Kd protein. This information suggests that
the segment that is required for more rapid transport ofC31
through a cell is present in the first halfofthe second domain
of the Kd molecule. To address whether the third domain
can interact with the first domain to allow transport, the C26
protein was analyzed. This protein is processed at approxi-
mately the same rate as the C31 protein (tti2 = 6 h) and
shows that the third domain has only a minor influence on
processing. Finally, theJ1 construct (tti2 = 45 min), which
contains the second half of the second domain from Kk,
while the rest of the molecule comes from Kd, is processed
normally and re-emphasizes the localization of the segments
that speed processing of the C31 protein to the first half of
the second domain. Therefore, the cell surface levels of the
hybrid proteins correlate with the rate of processing, sug-
gesting that the major contributor to the amount of C31
expressed at the cell surface is the rate of processing. Further-
more, we localize the structure that controls the rate of pro-
cessing to a combinatorial association between the first do-
main of Kd and the first half of the second domain.
In the case of the C25 molecule we obtain a different re-
sult. The C25 protein appears to be rapidly processed; the
mature form of the molecule appears in 90 min. TheJ3, C24,
and C23 proteins, which contain progressively more Kk
residues, are also processed quickly. The internal expression
of C25 is essentially the same as other hybrid proteins (data
not shown) and does not, therefore, account for the differ-
ence in cell surface expression. However, the lower C25 ex-
pression at the cell surface may be due to slower passage from
the trans-Golgi to the cell surface or, in an alteration in the
affinity of the antibodies we are using to analyze the C25
molecule at the cell surface.
We previously showed that the E3/19K protein of adeno-
virus 2 inhibits the transport of some MHC molecules to
the cell surface by specifically interacting with them in the
RER (20, 21). It has been shown that MHC class I mole-
cules must present foreign antigens at the plasma membrane
to T cells in order to generate an immune response against
the foreign antigen. Thus, the inhibition of MHC class I
expression at the cell surface represents an interesting viral
mechanism for subverting the immune response and possibly
for establishing viral persistence. In further studies, we demon-
strated that the Kd molecule binds the E3/19K protein,
while the Kk protein does not. The structures required for
this interaction mapped to the first 180 amino acids (oil and
a2 domains) in the Kd molecule. We investigated whether
the same segment of the cd and a2 domains which control
Kd transport are also involved in E3/19Kinduced transport
inhibition. Therefore, the J4 and theJ3 molecules were trans-
fected into the humanembryonic kidney cell line 293.12, which
had previously been transfected with the E3/19K gene and
the neomycin resistance marker. We used the hygromycin re-
sistance gene for cotransfection with the J3 and J4 genes to
select for clones harboring the new MHC genes. Individual
clones were grown up to be analyzed with other previously
derived chimeric gene transfectants. These cell lineswere pulsed
for 20 min with [35S]methionine and then chased for 90
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Discussion
Figure 8.
￿
Colocalization ofaminoacids controlling transport andE3/19K
binding. The a carbon coordinates ofthe first and second domains of the
MHCprotein HLAA2 are depicted. The black squares indicate the residues
that both determine the rate of intracellular transport of the H-2 Kd mol-
ecule and dictate its binding to the immunosubversive E3/19K protein
of adenovirus 2. The diamonds indicate the sites of N-glycosylation.
min. mAb specific for the transfected MHC class I protein
were used to detect binding of the adenovirusprotein to the
MHC protein via coimmunoprecipitation. Fig. 7 shows that
the Kd, C33, and C32-but not C31 or Kk-bind the E3/
19K protein, and that those molecules that bind the E3/19K
protein are not processed to their mature form 1.5 h after
the pulse. The J3 molecule does not bind the E3 /19K pro-
tein and its transport is not inhibited. Thus, the second half
of the second domain of Kd is not sufficient to bind the E3/
19K protein. On the other hand, the J4 molecule binds the
E3/19K protein, and its processing is inhibited. These data
localize the segment that binds the E3/19K protein to the
first half of the second domain of the Kd molecule or to a
combinatorial region comprising the first domain of Kd and
the first half of the second domain of Kd. Thus, the same
segment that controls transport of the Kd molecule out of
the RER also controls the binding to the E3/19K protein
which itself inhibits passage out of the RER.
Plasma membrane proteins that are synthesized in the RER
must be transported via the exocytotic pathway to the cell
surface. The amount of protein on the cell surface may be
determined by a number of factors, such as the rate of syn-
thesis, the rate of transport out of and back into the cell,
and ultimately by the rate of degradation. The rate of trans-
port of MHC class I molecules through the cell appears to
be primarily controlled by the rate of egress from the RER
to the cis-Golgi region (17, 18). The noncovalent interaction
of the class I H chain with the soluble protein X32-microglob-
ulin presumably alters the conformation ofthe molecule (12)
but is not the only factor that contributes to the rate of trans-
port. Recent data suggest that the binding of (j2-micro-
globulin to H chains in the RER is not spontaneous but ap-pears to be under the control of one or several factors. The
description of these factors was made possible by the genera-
tion of cell lines that did not allowthe association ofsynthe-
sized nascent chains of02-microglobulin and H chains in the
RER (14, 15). In one case, the association could be induced
by IFN-,y (15) while, in another, association was achieved
by somatic cell hybridization with a wild-type cell line (14).
In another intriguing study, the association could be induced
with peptides that are known to associate with the MHC
class I molecule during viral infection (16). Thus, this study
suggested that a peptide specifically induced the expression
of its own restriction element. Thus, it is clear from this and
other studies that the association and subsequent transport
out of the RER is under the control of positively acting
factor(s). The final level of control of MHC transport from
the RER is the subject of experiments presented here and
is an extension of other work, which describes that even after
binding S2-microglobulin, highly homologous MHC class
I proteins differ in their rate of transport to the cell surface
(17). We found that the majority ofC31 molecules that bound
to 02-microglobulin are transported at a very slow rate from
the RER to the cis-Golgi. During the first 12-24 h, most
of the C31 protein in splenocytes is Endo H sensitive and
it takes 12 h for the majority of the C31 molecules to acquire
Endo D sensitivity. These markers for protein transport and
processing place the C31 molecule in the RER or the cis-
Golgi 12 h after synthesis. Combining the results o£ Wil-
liams et al. (18) with our own, we suggest that the C31 pro-
tein is not transported rapidly because it lacks the correct
conformation required for transport. At present we can only
speculate on what disturbs the transport-competent struc-
tures in molecules like C31. We do not think that binding
of 02-microglobulin is reduced, as coimmunoprecipitation
of 02-microglobulin seems to be in the normal range (Fig.
2) . We favor the idea that discrete structures in the al/a2
superdomain are important for transport. This is in agree-
ment with the studies of Williams et al. (17), which show
that different MHC molecules have different rates of trans-
port, indicating that transport is controlled by polymorphic
amino acid residues. In light of the results of Townsend et
al. (16), we suggest that in our system, the mixed a1
(Kd)/ce2 (Kk) domain is able to bind a2-microglobulin, but
it is unable to bind a large number of peptides, which results
in a reduction oftransport and cell surface expression. How-
ever, we can not rule out the direct effect on oligomerization
and/or transport. We should note here that the 20,000-30,000
molecules of C31 that we can detect at the cell surface by
saturated binding assay seem to be normal, as evidenced by
theirhigher molecular weight form, theirinsensitivity to Endo
H after cell surface radio-iodination, and their demonstrated
function in CTL assays (29, 38).
We proceeded to localize the segment of the Kd protein
that contributes to faster processing to the C31 protein. The
rate of intracellular processing of the Kd-like constructs
(NH2-terminal domain derived from Kd) and the Kk-like
constructs (amino acid domains derived from Kk) were ana-
lyzed by pulse-chase experiments in 1T22-6 cells to deter-
mine whether their rate of processing is consistent with the
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cell surface expression of the hybrid proteins. Fig. 6 shows
that the processing of the C31 molecules is N15-fold slower
than most ofthe other molecules tested. For most molecules,
the time point at which 50% of the molecules are in their
higher molecular weight forms is between 45 and 90 min,
whereas for the C26 molecule it takes ti6 h and for C31 it
takes N10 h. In comparison with the C31 molecule, the J4
protein is rapidly processed. This corroborates the cell sur-
face analysis and again suggests that the first halfofthe second
domain of the Kd molecule contains residues that are impor-
tant for transport out of the endoplasmic reticulum (ER).
The C26 molecule is transported slowly through the cell,
and thus the third domain and the rest of the molecule does
not contribute significantly to the rate of processing. Anal-
ysis of the Jl protein that contains only the second half of
the second domain of Kt while the rest of the molecule is
from the Kd protein confirms the above statement. Accord-
ingly, the Jl protein is transported at a similar rate to the
Kd protein. Thus, we have identified a structure that in-
fluences the rate of Kd processing within the first half of the
second domain. The same stretch of amino acids does not
appear to be important for the efficient transport of the Kk
protein out of the ER; however, it may be important for the
transport of the Kk molecule from the trans-Golgi to the cell
surface (see Fig. 5).
It was then ofparticular interest to test whether the struc-
tural elements identified above are also involved in transport
inhibition ofMHC antigens in cells expressing the adenovirus
E3/19K protein. We have previously reported that the Kd,
but not the Kk protein, binds the E3/19K protein from
adenovirus 2 and, more specifically, that the first two do-
mains of Kd were responsible for binding this viral protein.
Intriguingly, the C31 protein does not bind (18). We trans-
fected the J4 and the J3 molecules into the human 293.12
cell line that had previously been transfected with the E3/19K
gene (21). J4- or J3-positive clones were expanded and ana-
lyzed for coimmunoprecipitation of the E3/19K protein with
either of these hybrid proteins (Fig. 7). We compared the
binding of these hybrid genes with those previously trans-
fected. We found that theJ4 construct bound very efficiently
to the E3/19K protein but that the J3 protein did not. The
J3 construct contains the first domain and half ofthe second
domain of Kk while the rest of the molecule is from Kd. The
binding of theJ4 construct suggests that in addition to pro-
tein transport, the polymorphic residues in the first half of
the second domain of the Kd also contribute to.the binding
ofthe E3/19K molecule. We suggest that this finding is not
coincidental. We speculate that we have localized the struc-
ture in Kd that is either required for oligomerization or is
recognized by a positively acting transport protein. Sym-
metrical packing into transport vesicles or oligomerization
may be required for efficient transport out o£ the ER. It is
possible that we have identified the structure in Kd largely
responsible for this phenomenon. The function of the E3/19K
protein may be to bind to this structure and disrupt assembly
into transport vesicles. The major alternative is that this struc-
ture is recognizedby a protein that actively transports MHC
molecules out of the ER. The C31 protein, lacking this struc-ture, would not be recognizedby the transport protein and
would not be efficiently transported. The function of the
E3/19K protein would then be to directly compete with the
transport protein for binding to the transport facilitation struc-
ture. At present we cannot differentiate between these two
possibilities; however, recent work by Livingstone et al., (41)
favors the latter model. They demonstrate the existence of
an MHC-linked gene, called cim, whichis required for efficient
transport to the cell surface of rat MHC class I molecules
after binding to 02-microglobulin in the ER.
The crystal structures of the HLAA2 and AW68 mole-
cules have been determined (5-7). Here, we assume that other
MHC class I proteins will have a similar structure, and we
also assume that the structure of the ER form of the MHC
class I protein is not grossly different from the papain frag-
ment. This information can be used to analyze the structure
in the second domain that contributes to transport andE3/19K
binding. The residues that are polymorphic between the C31
protein and the J4 protein (residues 99, 102, 114, 116, and
121) are localized within the crystal structure of HLAA2 in
Fig. 8. The amino acids at positions 99, 114, and 116 point
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into the putative peptide binding pocket, while the amino
acid at position 102 is localizedbelow thea helix ofthe second
domain and position 121 is on a loop between 0-pleated strand
02 and X83. Amino acids 99 and 102 make interdomain con-
tacts with the al domain, and disruption of these interac-
tions may disturb the gross structure of the superdomain.
On the other hand, amino acids 116 and 121 contact a2-mi-
croglobulin, and it is conceivable that these residues may also
affect the overall structure of MHC class I proteins while
leaving binding to a2-microglobulin unaffected. Finally, if
E3/19K directly competes with peptides at the binding cleft
or if peptides can alter the intracellular transport of MHC
molecules as suggested by Townsend et al. (16), residues that
affect peptide binding could influence both of these processes.
Thus, residues 99, 114, and 116 are candidates that couldcon-
trol both E3/19K binding and MHC transport. Changing
single amino acids in this region by site-directed mutagenesis
should allow us to identify the amino acid(s) important for
MHC transport and E3/19K binding and help to elucidate
the mechanisms involved.
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